M. John Chapman

33.4k total citations · 6 hit papers
197 papers, 15.0k citations indexed

About

M. John Chapman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, M. John Chapman has authored 197 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Surgery, 73 papers in Endocrinology, Diabetes and Metabolism and 38 papers in Cancer Research. Recurrent topics in M. John Chapman's work include Lipoproteins and Cardiovascular Health (82 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (62 papers) and Cholesterol and Lipid Metabolism (36 papers). M. John Chapman is often cited by papers focused on Lipoproteins and Cardiovascular Health (82 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (62 papers) and Cholesterol and Lipid Metabolism (36 papers). M. John Chapman collaborates with scholars based in France, United States and Australia. M. John Chapman's co-authors include Anatol Kontush, Maryse Guérin, Alexandros D. Tselepis, Philippe Lesnik, Éric Bruckert, Wilfried Le Goff, Alberico L. Catapano, Robert S. Rosenson, Sylvie Goulinet and Andrei C. Spósito and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. John Chapman

195 papers receiving 14.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein(a) as a cardiovascular risk factor: current status

2010 1.3k citations M. John Chapman, Jan Borén et al. European Heart Journal profile →
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

2006 598 citations Anatol Kontush, M. John Chapman profile →
Dysfunctional HDL and atherosclerotic cardiovascular disease

2015 567 citations M. John Chapman, Anatol Kontush et al. profile →
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1997 546 citations M. John Chapman et al. profile →
Variation inPCSK9andHMGCRand Risk of Cardiovascular Disease and Diabetes

2016 491 citations M. John Chapman et al. profile →
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

2011 391 citations M. John Chapman, Anatol Kontush et al. profile →

Peers

Countries citing papers authored by M. John Chapman

Since Specialization

Citations

This map shows the geographic impact of M. John Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. John Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. John Chapman more than expected).

Fields of papers citing papers by M. John Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. John Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. John Chapman. The network helps show where M. John Chapman may publish in the future.

Co-authorship network of co-authors of M. John Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of M. John Chapman. A scholar is included among the top collaborators of M. John Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. John Chapman. M. John Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differentiating EPA from EPA/DHA in cardiovascular risk reduction 2022 ·SHILAP Revista de lepidopterología ·Peter P. Tóth, M. John Chapman, Klaus G. Parhofer, John Nelson	20
2	Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort 2018 ·Atherosclerosis ·Sophie Béliard, Antonio Gallo, Emilie Duchêne, Alain Carrié, Randa Bittar, M. John Chapman, (unknown), Samir Saheb	9
3	Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis 2018 ·Journal of clinical lipidology ·Martin Adiels, M. John Chapman, Paul Robillard, Michel Krempf, Martine Laville, Jan Borén	18
4	Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·(unknown), Patrice Thérond, Svetlana A. Didichenko, Isabelle Guillas, M. John Chapman, Samuel D. Wright, Anatol Kontush	9
5	The year in cardiology 2015: prevention. 2016 ·Cardiologia Croatica ·M. John Chapman, Stefan Blankenberg, Ulf Landmesser	1
6	HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export 2015 ·Circulation Research ·(unknown), Mi‐Jurng Kim, Liming Hou, Wilfried Le Goff, M. John Chapman, Miranda Van Eck, Linda K. Curtiss, John R. Burnett, Siân P. Cartland, Carmel M. Quinn, Maaike Kockx, Anatol Kontush, Kerry‐Anne Rye, Leonard Kritharides, Wendy Jessup	240
7	Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Fabiana Hanna Rached, Marie Lhomme, Laurent Camont, (unknown), (unknown), Paul Robillard, Raúl D. Santos, Philippe Lesnik, Carlos Serrano, M. John Chapman, Anatol Kontush	46
8	An Overview of the New Frontiers in the Treatment of Atherogenic Dyslipidemias 2014 ·Clinical Pharmacology & Therapeutics ·Fabiana Hanna Rached, M. John Chapman, Anatol Kontush	36
9	Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy 2014 ·JACC. Cardiovascular imaging ·Rishi Puri, Steven E. Nissen, Mingyuan Shao, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	41
10	Factors underlying regression of coronary atheroma with potent statin therapy 2013 ·European Heart Journal ·Rishi Puri, Steven E. Nissen, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Julie St. John, Kathy Wolski, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	59
11	High Intestinal Cholesterol Absorption Is Associated With Cardiovascular Disease and Risk Alleles in ABCG8 and ABO 2013 ·Journal of the American College of Cardiology ·Günther Silbernagel, M. John Chapman, Bernd Genser, Marcus E. Kleber, Günter Fauler, Hubert Scharnagl, Tanja B. Grammer, Bernhard O. Boehm, Kari-Matti Mäkelä, Mika Kähönen, Rafael Carmena, Ernst Rietzschel, Éric Bruckert, John Deanfield, Tatu A. Miettinen, Olli T. Raitakari, Terho Lehtimäki, Winfried März	76
12	Human ATP–Binding Cassette G1 Controls Macrophage Lipoprotein Lipase Bioavailability and Promotes Foam Cell Formation 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), Michael W.T. Tanck, Ruud Out, Elise F. Villard, Bart Lammers, Laura Bouchareychas, Éric Frisdal, (unknown), Theo van Berkel, John J.P. Kastelein, Miranda Van Eck, J. Wouter Jukema, M. John Chapman, Geesje M. Dallinga‐Thie, Maryse Guérin, Wilfried Le Goff	32
13	REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY 2012 ·Journal of the American College of Cardiology ·Stephen J. Nicholls, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Rishi Puri, Yu Kataoka, Kathy Wolski, Steven E. Nissen	0
14	Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI 2011 ·Atherosclerosis ·Ying Zhao, Marieke Pennings, Carlos L.J. Vrins, Laura Calpe‐Berdiel, Menno Hoekstra, J. Kar Kruijt, Roelof Ottenhoff, Reeni B. Hildebrand, (unknown), Wendy Jessup, Wilfried Le Goff, M. John Chapman, Thierry Huby, Albert K. Groen, Theo J.C. van Berkel, Miranda Van Eck	31
15	Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: Relevance to vascular inflammation 2010 ·Nutrition Metabolism and Cardiovascular Diseases ·Christel Jublanc, Jean‐Louis Beaudeux, (unknown), Martine Raphaël, Rita Chadarévian, M. John Chapman, Dominique Bonnefont‐Rousselot, Éric Bruckert	33
16	Enhanced Dendritic Cell Survival Attenuates Lipopolysaccharide-Induced Immunosuppression and Increases Resistance to Lethal Endotoxic Shock 2008 ·The Journal of Immunology ·Emmanuel L. Gautier, Thierry Huby, Flora Saint-Charles, B. Ouzilleau, M. John Chapman, Philippe Lesnik	62
17	Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects 2007 ·Journal of Lipid Research ·(unknown), Emilie Duchêne, Zélie Julia, Wilfried Le Goff, Éric Bruckert, M. John Chapman, Maryse Guérin	45
18	Regulation of human CETP gene expression 2003 ·Journal of Lipid Research ·Wilfried Le Goff, Maryse Guérin, Laure Petit, M. John Chapman, (unknown)	24
19	Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins 2003 ·Atherosclerosis ·Andrei C. Spósito, Raúl D. Santos, (unknown), José Antônio Franchini Ramires, M. John Chapman, Raul Cavalcante Maranhão	23
20	Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations 1997 ·Fundamental and Clinical Pharmacology ·P M Laplaud, (unknown), M. John Chapman	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact